Investor Ideas #Potcasts; #Cannabis News and #Stocks on the Move
(TSXV: $FAF.V) (NASDAQ: $NEPT) (TSXV: $BEER.V) (CSE: $CURA.C)(TSX: $AVCN.TO)
Delta, Kelowna, BC –July 24,
2019 (Investorideas.com Newswire) www.Investorideas.com, a global news source
covering leading sectors including marijuana and hemp stocks and its potcast
site, www.potcasts.ca release today’s edition of Investorideas.com potcastsCM -
cannabis news and stocks to watch plus insight from thought leaders and
experts.
Listen to the podcast:
Read this in full
at https://www.investorideas.com/news/2019/cannabis-potcasts/07241FAF-NEPT-BEER-CURA-AVCN.asp
Today’s podcast overview/transcript:
Good
afternoon and welcome to another episode of Investorideas.com “potcasts”,
looking at cannabis news, stocks to watch as well as insights from thought
leaders and experts.
In today’s podcast we look at a few early
announcements.
Fire & Flower Holdings Corp. (TSXV: FAF), today announced that it has entered into a
subscription agreement with respect to a strategic investment by an indirect
wholly-owned subsidiary of Alimentation Couche-Tard Inc. (TSX: ATD.A) (TSX: ATD.B). The Company is also pleased to
announce that it has received conditional approval to post its common shares
for trading on the Toronto Stock Exchange.
The
Subscription Agreement allows for Couche-Tard to obtain a controlling interest
in the Company with an aggregate investment of more than $380,000,000 of growth
capital for Fire & Flower's global expansion.
Fire
& Flower has demonstrated that it is capable of rapidly scaling its retail
platform through a best-of-class store concept, a leading digital platform and
a focus on the safe, responsible and lawful sale of cannabis. This investment
will provide Fire & Flower with additional funds to support the further
development of its proprietary Hifyre™ digital retail platform and expansion of
its retail store network across Canada and internationally where legally
permitted.
Concurrent
with the closing of the Transaction, the Company will uplist to the TSX.
"This
strategic investment by Couche-Tard, one of the world's largest retailers, is
transformative for Fire & Flower. The retail cannabis platform we developed
marries a best-in-class in-store experience with our proprietary Hifyre™
digital infrastructure and this is a huge vote of confidence in the
platform," shared Trevor Fencott, Fire & Flower's Chief Executive
Officer. "The support of Couche-Tard's world-class leadership team,
coupled with their impressive international footprint which includes major
markets such as the US, Mexico and Europe, provide us with outstanding
opportunities for aggressive growth."
"Couche-Tard
is excited to make this strategic investment in one of the fastest growing
cannabis 'pure-play' retailers," said Brian Hannasch, President and CEO of
Couche-Tard. "This investment in Fire & Flower, with a path to a
controlling stake, will enable us to leverage their leadership, network and
advanced digital platform to accelerate our journey in this new and flourishing
sector."
Neptune Wellness Solutions Inc. (NASDAQ: NEPT) (TSX: NEPT), a North American leader in
extraction, formulation and turnkey packaging solutions, has completed the
acquisition of the assets of SugarLeaf Labs, LLC and Forest Remedies LLC. The
acquisition was first announced on May 9, 2019.
"The acquisition of SugarLeaf,
combined with Neptune allows us to create a leading North American extraction
platform with significant capacity available to serve our customers on both
sides of the border. Furthermore, considering the significant growth
anticipated in hemp-based products, this acquisition provides Neptune with
capabilities to satisfy a wide array of clients. Finally, we anticipate a
significant contribution from this acquisition, as indicated by the large
earnout structure providing adequate risk sharing," said Michael
Cammarata, Neptune President and CEO.
Hill Street Beverage Company Inc. (TSXV: BEER) and Lexaria Bioscience Corp. (OTCQX: LXRP) (CSE: LXX) today announced a multi-faceted expansion of
their relationship .
Hill Street and Lexaria have entered into
a Joint Manufacturing Partnership valid for 10 years to produce DehydraTECH™
commercial products under a new brand to be announced, including both processed
THC and CBD powders in the form of compressed tablets, capsules, or sachets for
new consumer products for sale in Canada and for export where permitted,
subject to Health Canada approval. These new products could allow consumers to
infuse any beverage with cannabis without affecting the taste, smell, or other
physical attributes. The JMP will also produce similar powders for use as an
ingredient for licensed producers in Canada seeking to use Lexaria's advanced
infusion technologies in beverages, edibles and topicals.
Manufacturing will be done at Hill
Street's recently announced OneLeaf Cannabis cultivation and processing
facility in Regina, Saskatchewan, subject to closing of the OneLeaf
acquisition, and its licensing by Health Canada. Hill Street will own and
manage all aspects of the manufacturing business under Lexaria's own license
and patents for DehydraTECH and its related processes. Profits from this
business unit will be shared equally between Hill Street and Lexaria.
Both companies anticipate greatly
enhanced cashflows from the JMP, and for Lexaria in particular, the JMP marks
its first opportunity to more directly benefit from the emerging federally
legal cannabis edibles industry in Canada.
The new JMP between Hill Street and
Lexaria will, for the first time ever, permit intermediate ingredients made
from cannabis processed by Lexaria's DehydraTECH to be legally sold within
Canada on a B2B basis between LP's and others licensed by Health Canada to
manufacture cannabis-infused edibles, including both THC and CBD. Cannabis and
hemp powders produced using DehydraTECH are extremely stable with two to
three-year shelf life, are odorless and tasteless, and yet deliver full
spectrum experiences for consumers without having to compromise with isolates
and distillates of cannabis oil.
In addition to the manufacturing
partnership, Hill Street has acquired a global semi-exclusive license (with
minor exceptions) to utilize Lexaria's DehydraTECH™ THC beverage infusion
technology and a global non-exclusive license to utilize Lexaria's DehydraTECHTM
CBD beverage infusion technology around the world valid for 10 years. This
expands the July 31, 2018 license award to Hill Street to use DehydraTECH for
THC beverage formulation in Canada only, and positions Hill Street as the only
company in the world to have earned a license to use DehydraTECH globally.
License royalties for the use of DehydraTECH will be activated as Hill Street
enters national markets that have legally allowed the sale of products using
Lexaria's technologies.
Hill Street's Chairman & CEO, Terry
Donnelly, declared, "When we first began our relationship with Lexaria it
was based on a comprehensive competitive review of the market with a single
uncompromising vision: to find a technology partner who could provide water
soluble cannabis, with zero impact on the award-winning taste and aroma of our
products. Lexaria has proven themselves time and again to be the ideal infusion
platform for our products, to be committed to continuous improvement and
innovation, and to deliver the best consumer experience. This partnership takes
our relationship to a whole new level, which we believe will help to set a
global standard for excellence that consumers are looking for in cannabis edibles
and beverages. Our manufacturing partnership will make this technology
available to LP's interested in producing world class edibles, ensuring our
industry is able to provide consumers broad-based access to this incredible
technology in nearly any product format."
Curaleaf Holdings, Inc. (CSE: CURA) (OTCQX: CURLF) announced today the opening of its 25th
Florida dispensary at 610 Lake Minnie Drive, as the company continues to expand
rapidly throughout the state. Curaleaf has the largest cannabis dispensary
footprint in the US, with 48 dispensaries across the country.
"In opening our 3rd
Orlando area medical marijuana dispensary, we are proud to be able to provide
patients in the communities of Sanford, Lake Mary, Lake Monroe, Longwood,
Winter Springs, and Midway, Florida with access to Curaleaf's premium quality
products and educational resources," shared Joe Lusardi, Curaleaf CEO.
Curaleaf is commemorating the grand
opening of Sanford's first medical marijuana dispensary by providing a
sneak-preview to its newest product - Curaleaf Shatter, at the dispensary.
Processed using the industry's cleanest, most medically precise extraction and
purification methods combined with decades of horticultural experience,
Curaleaf Shatter offers patients with qualifying medical conditions a new
product option that physicians may consider for their patients. Curaleaf
medical cannabis products are also available in the forms of capsules, oils,
distillates, concentrates, vaporizer pens, pre-rolls, smokable flower, and
topical creams.
Curaleaf's Sanford dispensary will
celebrate its grand opening with an event in partnership with the Greater
Sanford Regional Chamber of Commerce on Thursday, July 25, 2019. Dispensary
operating hours are Monday through Friday, 10am – 7pm; Saturday, 10am – 5pm; and
Sunday, Noon – 5pm. Free ample parking
is available onsite. The State of Florida's Office of Medical Marijuana Use
Registry requires an order from a qualified Florida ordering physician and a
State of Florida medical marijuana card to obtain medical marijuana products.
Avicanna Inc. (TSX: AVCN) a biopharmaceutical company
focused on the development, manufacturing and commercialization of
plant-derived cannabinoid-based products, announced the commencement of phase I
clinical trials on three of its derma-cosmetic products.
Centro de Atención e Investigación Médica
CAIMED S.A.S. ("CAIMED")
has commenced clinical studies on Avicanna's Pura Earth™ derma-cosmetics
products in order to demonstrate their effectiveness with specific cosmetic
endpoints, such as reduction of fine lines associated with aging, efficacy as a
moisturizer for eczema prone skin, and reduction of sebum and redness
attributed to acne. In connection with such clinical studies, CAIMED is
currently in the process of recruitment for the Company's intensive conditioner
trial for eczema prone skin and expects recruitment for the clear skin and
regenerative serum trials to begin in August, with a total of 54 patients
expected to be recruited per trial. Once applications have been administered to
patients, the trials for clear skin and intensive conditioner are expected to
last four weeks with the trial for the regenerative serum expected to last
eight weeks. The studies are being completed in Colombia and results are
expected to be available prior to commercial launch during the fourth quarter
of 2019. Additionally, the Company is unaware of any other trials on https://clinicaltrials.gov involving cannabinoids in
Colombia or on derma-cosmetics containing cannabinoids in the world.
"At CAIMED we are very excited and
proud of leading the medical cannabis clinical research with Avicanna´s
dermatology and cosmetic products. The studies have been designed and are being
developed with the highest standards in order to build strong evidence in this
new challenging heath care opportunity" said Humberto Reynales, Executive
Director of CAIMED.
Investor ideas reminds all listeners to read our disclaimers and
disclosures on the
Investorideas.com website and this podcast is not an endorsement
to buy products or services or securities. Investors are reminded all
investment involves risk and possible loss of investment
Subscribe to the new cannabis podcast series:
Investorideas.com podcasts are also
available on iTunes, Spotify, Google
Play Music, Stitcher, Spreaker, YouTube
via Spreaker, iHeartradio and Tunein.
Potcasts is now a certified word mark Trademark
on the blockchain through Cognate, Inc. CM Certification-Registration Number:
10468217708
About Investorideas.com - News that Inspires Big Investing Ideas
Investorideas.com is a recognized news
source publishing third party news and press releases plus we create original
financial content. Learn about investing in stocks and sector trends
from Investorideas.com with our news alerts , articles , podcasts and videos talking about cannabis, crypto,
technology including AI and IoT ,
mining ,sports biotech, water, renewable energy and more . Investorideas.com
original branded content includes the daily Crypto Corner and Podcast, Play
by Play sports and stock news column, Investor Ideas #Potcasts #Cannabis News
and Stocks on the Move podcast and column,
Cleantech and Climate Change Podcast and
the AI
Eye Podcast and column covering developments in
AI.
Disclaimer/Disclosure: Investorideas.com is a
digital publisher of third party sourced news, articles and equity research as
well as creates original content, including video, interviews and articles.
Original content created by investorideas is protected by copyright laws other
than syndication rights. Our site does not make recommendations for purchases
or sale of stocks, services or products. Nothing on our sites should be
construed as an offer or solicitation to buy or sell products or securities.
All investing involves risk and possible losses. This site is currently
compensated for news publication and distribution, social media and marketing,
content creation and more. Disclosure is posted for each compensated news
release, content published /created if required but otherwise the news was not
compensated for and was published for the sole interest of our readers and
followers. Contact management and IR of each company directly regarding
specific questions.
More disclaimer info: https://www.investorideas.com/About/Disclaimer.asp Learn
more about publishing your news release and our other news services on the
Investorideas.com newswire https://www.investorideas.com/News-Upload/ and
tickertagstocknews.com
Global investors must adhere to regulations of each
country. Please read Investorideas.com privacy policy: https://www.investorideas.com/About/Private_Policy.asp
Investor Ideas does not condone the use of cannabis except where
permissible by law. Our site does not possess, distribute, or sell cannabis
products.
Follow us on Social Media
Contact Investorideas.com
800-665-0411
No comments:
Post a Comment